今日焦点！大商所温度指数：助力产业发展，服务社会民生

大商所温度指数：助力产业发展，服务社会民生

北京，2024年6月17日 - 今天是第62个世界气象日，主题为“气象、气候与水”。近年来，随着全球气候变化加剧，极端天气事件频发，对农业生产、能源消费、基础设施建设等领域造成重大影响。在大宗商品市场，气温指数作为一种重要的风险管理工具，正日益受到关注。

大商所作为全球领先的期货交易所，早在2009年就与中央气象台合作，推出了温度指数。经过十余年的发展，大商所温度指数已成为服务产业发展、保障社会民生的重要工具。

“从0到1到N”，大商所温度指数不断创新

大商所温度指数从最初的单一品种、单一地域，发展到如今的多品种、多地域、多层次的产品体系，为市场参与者提供了更加丰富的风险管理工具。

• **产品种类丰富：**目前，大商所已推出涵盖全国15个城市的日平均温度指数、月累积平均温度指数、制热指数和制冷指数等多种产品，能够满足不同产业、不同地域的风险管理需求。
• **数据权威可靠：**大商所温度指数基于中央气象台权威气象数据，数据来源真实可靠，具有较强的公信力。
• **交易活跃透明：**大商所温度指数在期货市场公开交易，价格发现功能完善，能够有效反映市场对未来气温变动的预期。

服务产业发展，保障社会民生

大商所温度指数已广泛应用于农业、能源、交通、制造等多个领域，为产业发展和社会民生提供了有效的风险保障。

• **农业：**大商所温度指数可以帮助农户规避因高温、低温等天气因素造成的产量损失，为农业生产提供稳定性。
• **能源：**大商所温度指数可以帮助能源企业对冲因气温变化导致的能源需求波动风险，提高能源生产和供应的效率。
• **交通：**大商所温度指数可以帮助交通运输企业对冲因极端天气事件导致的交通运输成本增加风险，保障交通运输的平稳运行。
• **制造：**大商所温度指数可以帮助制造企业对冲因气温变化导致的生产成本增加风险，提高生产效率。

未来展望

未来，大商所将继续加强与中央气象台的合作，不断完善温度指数产品体系，提升产品服务质量，为产业发展和社会民生提供更加有效的风险管理工具。

大商所温度指数的创新实践，是金融服务实体经济的一个典范。通过发挥期货市场的风险管理功能，大商所为产业发展和社会民生提供了重要的支持，为建设生态文明、促进可持续发展作出了积极贡献。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.